

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.45649119 |
| 2 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.19234577 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.19234577 |
| 4 | DNA deamination (GO:0045006) | 4.60487391 |
| 5 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.25302679 |
| 6 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 4.25302679 |
| 7 | antigen processing and presentation of endogenous antigen (GO:0019883) | 4.21240088 |
| 8 | regulation of gamma-delta T cell activation (GO:0046643) | 4.14923468 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.98229075 |
| 10 | ribosomal small subunit biogenesis (GO:0042274) | 3.95480995 |
| 11 | detection of bacterium (GO:0016045) | 3.85987558 |
| 12 | detection of other organism (GO:0098543) | 3.85322985 |
| 13 | positive regulation by symbiont of host defense response (GO:0052509) | 3.65803111 |
| 14 | modulation by symbiont of host defense response (GO:0052031) | 3.65803111 |
| 15 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.65803111 |
| 16 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.65803111 |
| 17 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.65803111 |
| 18 | modulation by symbiont of host immune response (GO:0052553) | 3.65803111 |
| 19 | macrophage activation involved in immune response (GO:0002281) | 3.57964773 |
| 20 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 3.52359360 |
| 21 | positive thymic T cell selection (GO:0045059) | 3.48578588 |
| 22 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.42019561 |
| 23 | negative regulation of interleukin-12 production (GO:0032695) | 3.39719527 |
| 24 | interferon-gamma production (GO:0032609) | 3.37152243 |
| 25 | proteasome assembly (GO:0043248) | 3.35420877 |
| 26 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.35106880 |
| 27 | rRNA modification (GO:0000154) | 3.34602033 |
| 28 | B cell mediated immunity (GO:0019724) | 3.31175240 |
| 29 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.30803308 |
| 30 | leukocyte aggregation (GO:0070486) | 3.30157035 |
| 31 | positive regulation of B cell differentiation (GO:0045579) | 3.28286225 |
| 32 | granulocyte activation (GO:0036230) | 3.27328035 |
| 33 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.23996184 |
| 34 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.23693683 |
| 35 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.23462826 |
| 36 | regulation of regulatory T cell differentiation (GO:0045589) | 3.21350333 |
| 37 | detection of external biotic stimulus (GO:0098581) | 3.19703133 |
| 38 | regulation of T cell tolerance induction (GO:0002664) | 3.19541285 |
| 39 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.16852078 |
| 40 | B cell receptor signaling pathway (GO:0050853) | 3.15165132 |
| 41 | response to interferon-beta (GO:0035456) | 3.13695470 |
| 42 | mitochondrial DNA replication (GO:0006264) | 3.12318938 |
| 43 | tolerance induction (GO:0002507) | 3.09922619 |
| 44 | cellular response to type I interferon (GO:0071357) | 3.09502046 |
| 45 | type I interferon signaling pathway (GO:0060337) | 3.09502046 |
| 46 | cellular response to interleukin-15 (GO:0071350) | 3.09135709 |
| 47 | negative regulation of T cell mediated immunity (GO:0002710) | 3.08116974 |
| 48 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.07447415 |
| 49 | ribosomal small subunit assembly (GO:0000028) | 3.05827417 |
| 50 | response to type I interferon (GO:0034340) | 3.05799555 |
| 51 | negative regulation of innate immune response (GO:0045824) | 3.01093817 |
| 52 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.99259560 |
| 53 | response to protozoan (GO:0001562) | 2.97595765 |
| 54 | myeloid cell activation involved in immune response (GO:0002275) | 2.97285252 |
| 55 | regulation of isotype switching to IgG isotypes (GO:0048302) | 2.97203509 |
| 56 | regulation of tolerance induction (GO:0002643) | 2.97071262 |
| 57 | NIK/NF-kappaB signaling (GO:0038061) | 2.96939891 |
| 58 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.96293929 |
| 59 | natural killer cell activation involved in immune response (GO:0002323) | 2.96089130 |
| 60 | response to peptidoglycan (GO:0032494) | 2.95069772 |
| 61 | regulation of B cell differentiation (GO:0045577) | 2.94945735 |
| 62 | dendritic cell chemotaxis (GO:0002407) | 2.94288379 |
| 63 | sequestering of actin monomers (GO:0042989) | 2.93602148 |
| 64 | termination of RNA polymerase III transcription (GO:0006386) | 2.93467586 |
| 65 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.93467586 |
| 66 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.92964281 |
| 67 | ribosomal large subunit biogenesis (GO:0042273) | 2.92539958 |
| 68 | germinal center formation (GO:0002467) | 2.91654141 |
| 69 | purine deoxyribonucleotide catabolic process (GO:0009155) | 2.90211844 |
| 70 | positive regulation of antigen processing and presentation (GO:0002579) | 2.90099051 |
| 71 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.90033648 |
| 72 | T cell selection (GO:0045058) | 2.90010303 |
| 73 | cellular extravasation (GO:0045123) | 2.89927060 |
| 74 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.89012824 |
| 75 | thymic T cell selection (GO:0045061) | 2.88275955 |
| 76 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.87893532 |
| 77 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.87893532 |
| 78 | cellular response to interferon-beta (GO:0035458) | 2.87837652 |
| 79 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.86712827 |
| 80 | positive T cell selection (GO:0043368) | 2.85178934 |
| 81 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 2.84489746 |
| 82 | GDP-mannose metabolic process (GO:0019673) | 2.83963844 |
| 83 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.83777775 |
| 84 | cytidine deamination (GO:0009972) | 2.83685200 |
| 85 | cytidine metabolic process (GO:0046087) | 2.83685200 |
| 86 | cytidine catabolic process (GO:0006216) | 2.83685200 |
| 87 | DNA damage response, detection of DNA damage (GO:0042769) | 2.83632299 |
| 88 | lymphocyte chemotaxis (GO:0048247) | 2.81834021 |
| 89 | rRNA methylation (GO:0031167) | 2.80350772 |
| 90 | detection of biotic stimulus (GO:0009595) | 2.80239339 |
| 91 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.80056237 |
| 92 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.79417828 |
| 93 | DNA replication checkpoint (GO:0000076) | 2.79139343 |
| 94 | RNA destabilization (GO:0050779) | 2.77902891 |
| 95 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.77606028 |
| 96 | cotranslational protein targeting to membrane (GO:0006613) | 2.77171233 |
| 97 | viral transcription (GO:0019083) | 2.76610705 |
| 98 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 2.75775447 |
| 99 | pseudouridine synthesis (GO:0001522) | 2.75718861 |
| 100 | myeloid dendritic cell activation (GO:0001773) | 2.75447526 |
| 101 | myeloid dendritic cell differentiation (GO:0043011) | 2.75324671 |
| 102 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.74418260 |
| 103 | positive regulation of defense response to virus by host (GO:0002230) | 2.74330849 |
| 104 | protein targeting to ER (GO:0045047) | 2.73947640 |
| 105 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.73395889 |
| 106 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.73295686 |
| 107 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 2.73142367 |
| 108 | positive regulation of tolerance induction (GO:0002645) | 2.72404095 |
| 109 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.70608094 |
| 110 | response to host immune response (GO:0052572) | 2.70608094 |
| 111 | response to muramyl dipeptide (GO:0032495) | 2.70460620 |
| 112 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.70314138 |
| 113 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.70212123 |
| 114 | regulation of cell killing (GO:0031341) | 2.67862745 |
| 115 | response to interleukin-15 (GO:0070672) | 2.67165565 |
| 116 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.67148363 |
| 117 | regulation of mast cell degranulation (GO:0043304) | 2.66942332 |
| 118 | * regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.66740729 |
| 119 | detection of molecule of bacterial origin (GO:0032490) | 2.65615368 |
| 120 | cellular response to interferon-gamma (GO:0071346) | 2.65155485 |
| 121 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.64159961 |
| 122 | protein localization to endoplasmic reticulum (GO:0070972) | 2.63018729 |
| 123 | translational termination (GO:0006415) | 2.62844322 |
| 124 | negative regulation of type 2 immune response (GO:0002829) | 2.62070633 |
| 125 | antigen receptor-mediated signaling pathway (GO:0050851) | 2.62057334 |
| 126 | T cell migration (GO:0072678) | 2.61509727 |
| 127 | telomere maintenance via recombination (GO:0000722) | 2.61078367 |
| 128 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.60573392 |
| 129 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.58731985 |
| 130 | neutrophil activation involved in immune response (GO:0002283) | 2.58455477 |
| 131 | tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388) | 2.55655281 |
| 132 | RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394) | 2.55655281 |
| 133 | immunoglobulin mediated immune response (GO:0016064) | 2.55581789 |
| 134 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.55158429 |
| 135 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.55158429 |
| 136 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.55158429 |
| 137 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.54853821 |
| 138 | DNA-dependent DNA replication (GO:0006261) | 2.54414882 |
| 139 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.54248630 |
| 140 | maturation of SSU-rRNA (GO:0030490) | 2.53183616 |
| 141 | muscle organ morphogenesis (GO:0048644) | 2.52759373 |
| 142 | signal peptide processing (GO:0006465) | 2.52676332 |
| 143 | transcription from RNA polymerase I promoter (GO:0006360) | 2.51552480 |
| 144 | negative T cell selection (GO:0043383) | 2.51200148 |
| 145 | ribosome biogenesis (GO:0042254) | 2.50815467 |
| 146 | positive regulation of isotype switching (GO:0045830) | 2.50401241 |
| 147 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.49666275 |
| 148 | * regulation of antigen processing and presentation (GO:0002577) | 2.49654733 |
| 149 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.48408849 |
| 150 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.48163904 |
| 151 | ribosome assembly (GO:0042255) | 2.47774892 |
| 152 | RNA methylation (GO:0001510) | 2.47017022 |
| 153 | neutrophil activation (GO:0042119) | 2.46184527 |
| 154 | DNA strand elongation (GO:0022616) | 2.44683996 |
| 155 | translation (GO:0006412) | 2.44303285 |
| 156 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.44102391 |
| 157 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.43675655 |
| 158 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.43317159 |
| 159 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.43317159 |
| 160 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.42129425 |
| 161 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.42129425 |
| 162 | cellular component biogenesis (GO:0044085) | 2.42072504 |
| 163 | negative thymic T cell selection (GO:0045060) | 2.41756915 |
| 164 | regulation of RIG-I signaling pathway (GO:0039535) | 2.41706484 |
| 165 | rRNA processing (GO:0006364) | 2.40540696 |
| 166 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.40538360 |
| 167 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.39891307 |
| 168 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.39589804 |
| 169 | maturation of 5.8S rRNA (GO:0000460) | 2.39129698 |
| 170 | cellular response to exogenous dsRNA (GO:0071360) | 2.39095753 |
| 171 | respiratory burst (GO:0045730) | 2.39045226 |
| 172 | defense response to protozoan (GO:0042832) | 2.38771815 |
| 173 | mRNA modification (GO:0016556) | 2.36842532 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.00361080 |
| 2 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.63592683 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.62557732 |
| 4 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.52827482 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.47184093 |
| 6 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.41967691 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.37202889 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.12714992 |
| 9 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.12387249 |
| 10 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 2.95031624 |
| 11 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.92412240 |
| 12 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.67796028 |
| 13 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.50165649 |
| 14 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.50138669 |
| 15 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.49802676 |
| 16 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.39920314 |
| 17 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.33090660 |
| 18 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.32969146 |
| 19 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.28473114 |
| 20 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.20256057 |
| 21 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.18133533 |
| 22 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.18001211 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.16391349 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.15335126 |
| 25 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 2.15328922 |
| 26 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.14505969 |
| 27 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.11066201 |
| 28 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.10766480 |
| 29 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.09025765 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.08403603 |
| 31 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.07726546 |
| 32 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.06286400 |
| 33 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.01165168 |
| 34 | UTX_26944678_Chip-Seq_JUKART_Human | 2.00795065 |
| 35 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.97191633 |
| 36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.93921727 |
| 37 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.91504516 |
| 38 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.88313539 |
| 39 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.83252070 |
| 40 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.83146044 |
| 41 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.81204320 |
| 42 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.79984283 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.78089469 |
| 44 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.76018452 |
| 45 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.75805643 |
| 46 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.75805643 |
| 47 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.75805643 |
| 48 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.74929148 |
| 49 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.73926068 |
| 50 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.69855023 |
| 51 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.67847916 |
| 52 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.67300778 |
| 53 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.64940341 |
| 54 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.62989059 |
| 55 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.62320889 |
| 56 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.61073789 |
| 57 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.59451482 |
| 58 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.58424879 |
| 59 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56991643 |
| 60 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.55317712 |
| 61 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.54554283 |
| 62 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.53285771 |
| 63 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53024381 |
| 64 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.52613997 |
| 65 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.50004445 |
| 66 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.49469108 |
| 67 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46019187 |
| 68 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.44884056 |
| 69 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.44380860 |
| 70 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.43900716 |
| 71 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.41739505 |
| 72 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.41672536 |
| 73 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.41148482 |
| 74 | GATA3_26560356_Chip-Seq_TH2_Human | 1.40563256 |
| 75 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.39950757 |
| 76 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.39692273 |
| 77 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39277680 |
| 78 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37922024 |
| 79 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.37790866 |
| 80 | MYB_26560356_Chip-Seq_TH1_Human | 1.36949767 |
| 81 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.35917892 |
| 82 | * MYB_26560356_Chip-Seq_TH2_Human | 1.34738397 |
| 83 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.33742353 |
| 84 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.32699952 |
| 85 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.31240567 |
| 86 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.30623022 |
| 87 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.29942211 |
| 88 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29844155 |
| 89 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.28952896 |
| 90 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.28200526 |
| 91 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.27514306 |
| 92 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.27506909 |
| 93 | GATA1_19941826_ChIP-Seq_K562_Human | 1.27497044 |
| 94 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26892090 |
| 95 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.26041917 |
| 96 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.22745044 |
| 97 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.19095839 |
| 98 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.18502330 |
| 99 | GATA1_22025678_ChIP-Seq_K562_Human | 1.18201634 |
| 100 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.18080874 |
| 101 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.17533988 |
| 102 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.17360096 |
| 103 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.16943509 |
| 104 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.16419780 |
| 105 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.16260777 |
| 106 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.14543597 |
| 107 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.13658862 |
| 108 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13020965 |
| 109 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.12704520 |
| 110 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.11974106 |
| 111 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.11684966 |
| 112 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.11527289 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 1.10218857 |
| 114 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10028513 |
| 115 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.09840201 |
| 116 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08473268 |
| 117 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.07943911 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07833423 |
| 119 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.07660815 |
| 120 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.06961452 |
| 121 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.06268533 |
| 122 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.04819974 |
| 123 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.04779839 |
| 124 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04454590 |
| 125 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.04243010 |
| 126 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.03959500 |
| 127 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.03539224 |
| 128 | MAF_26560356_Chip-Seq_TH1_Human | 1.03488153 |
| 129 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.02454532 |
| 130 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.00995874 |
| 131 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00662521 |
| 132 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.99968009 |
| 133 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.99599456 |
| 134 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.98747425 |
| 135 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.97577994 |
| 136 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.96811908 |
| 137 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.96376477 |
| 138 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.96235923 |
| 139 | P300_27268052_Chip-Seq_Bcells_Human | 0.96068907 |
| 140 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.95551629 |
| 141 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.95080505 |
| 142 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.94919221 |
| 143 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94660632 |
| 144 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93632900 |
| 145 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.93106484 |
| 146 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.93088470 |
| 147 | VDR_21846776_ChIP-Seq_THP-1_Human | 0.92877004 |
| 148 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.92837979 |
| 149 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.92378883 |
| 150 | * FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.92301390 |
| 151 | GATA2_19941826_ChIP-Seq_K562_Human | 0.91898588 |
| 152 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.91091801 |
| 153 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.90948582 |
| 154 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90944895 |
| 155 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90261812 |
| 156 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.89873289 |
| 157 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.86772352 |
| 158 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.86306816 |
| 159 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.86063863 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 4.13897466 |
| 2 | MP0005671_abnormal_response_to | 3.15559911 |
| 3 | MP0009785_altered_susceptibility_to | 2.93682357 |
| 4 | MP0001790_abnormal_immune_system | 2.80206283 |
| 5 | MP0005387_immune_system_phenotype | 2.80206283 |
| 6 | MP0005000_abnormal_immune_tolerance | 2.67797504 |
| 7 | MP0008057_abnormal_DNA_replication | 2.67459406 |
| 8 | MP0003763_abnormal_thymus_physiology | 2.66660664 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.66464857 |
| 10 | MP0001800_abnormal_humoral_immune | 2.65340655 |
| 11 | MP0005025_abnormal_response_to | 2.54141199 |
| 12 | MP0006082_CNS_inflammation | 2.52753447 |
| 13 | MP0000685_abnormal_immune_system | 2.52233054 |
| 14 | MP0001853_heart_inflammation | 2.47848128 |
| 15 | MP0002723_abnormal_immune_serum | 2.38452283 |
| 16 | MP0003436_decreased_susceptibility_to | 2.32791127 |
| 17 | MP0002452_abnormal_antigen_presenting | 2.29376145 |
| 18 | MP0002420_abnormal_adaptive_immunity | 2.19911447 |
| 19 | MP0001819_abnormal_immune_cell | 2.19792073 |
| 20 | MP0003693_abnormal_embryo_hatching | 2.19719147 |
| 21 | MP0003724_increased_susceptibility_to | 2.18609959 |
| 22 | MP0005075_abnormal_melanosome_morpholog | 2.02768388 |
| 23 | MP0002277_abnormal_respiratory_mucosa | 2.01341031 |
| 24 | MP0002419_abnormal_innate_immunity | 2.00999617 |
| 25 | MP0005310_abnormal_salivary_gland | 1.96824120 |
| 26 | MP0003300_gastrointestinal_ulcer | 1.94755119 |
| 27 | MP0002138_abnormal_hepatobiliary_system | 1.94291926 |
| 28 | MP0005058_abnormal_lysosome_morphology | 1.92478145 |
| 29 | MP0009333_abnormal_splenocyte_physiolog | 1.92346829 |
| 30 | MP0003183_abnormal_peptide_metabolism | 1.92193275 |
| 31 | MP0004381_abnormal_hair_follicle | 1.85933345 |
| 32 | MP0008058_abnormal_DNA_repair | 1.84575768 |
| 33 | MP0000716_abnormal_immune_system | 1.84405438 |
| 34 | MP0002398_abnormal_bone_marrow | 1.83166054 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.82433506 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.80158902 |
| 37 | MP0009379_abnormal_foot_pigmentation | 1.76832213 |
| 38 | MP0002139_abnormal_hepatobiliary_system | 1.74025939 |
| 39 | MP0000689_abnormal_spleen_morphology | 1.72462174 |
| 40 | MP0002405_respiratory_system_inflammati | 1.67812328 |
| 41 | MP0001873_stomach_inflammation | 1.66596038 |
| 42 | MP0002722_abnormal_immune_system | 1.64871836 |
| 43 | MP0000465_gastrointestinal_hemorrhage | 1.61743475 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.55552109 |
| 45 | MP0001845_abnormal_inflammatory_respons | 1.53902461 |
| 46 | MP0002429_abnormal_blood_cell | 1.53157430 |
| 47 | MP0003172_abnormal_lysosome_physiology | 1.51829438 |
| 48 | MP0009840_abnormal_foam_cell | 1.50792020 |
| 49 | MP0004957_abnormal_blastocyst_morpholog | 1.50411695 |
| 50 | MP0002254_reproductive_system_inflammat | 1.49086619 |
| 51 | MP0008469_abnormal_protein_level | 1.47122952 |
| 52 | MP0003186_abnormal_redox_activity | 1.42558426 |
| 53 | MP0002166_altered_tumor_susceptibility | 1.41715657 |
| 54 | MP0001986_abnormal_taste_sensitivity | 1.40895427 |
| 55 | MP0000703_abnormal_thymus_morphology | 1.37820102 |
| 56 | MP0002132_abnormal_respiratory_system | 1.36633334 |
| 57 | MP0003075_altered_response_to | 1.35315993 |
| 58 | MP0004510_myositis | 1.35246748 |
| 59 | MP0000858_altered_metastatic_potential | 1.34368183 |
| 60 | MP0009278_abnormal_bone_marrow | 1.34194845 |
| 61 | MP0002006_tumorigenesis | 1.32191749 |
| 62 | MP0005451_abnormal_body_composition | 1.31338192 |
| 63 | MP0001348_abnormal_lacrimal_gland | 1.31324574 |
| 64 | MP0003077_abnormal_cell_cycle | 1.30077120 |
| 65 | MP0005174_abnormal_tail_pigmentation | 1.27722788 |
| 66 | MP0004947_skin_inflammation | 1.27679988 |
| 67 | MP0009764_decreased_sensitivity_to | 1.25314996 |
| 68 | MP0005360_urolithiasis | 1.22763441 |
| 69 | MP0002396_abnormal_hematopoietic_system | 1.20830258 |
| 70 | MP0000613_abnormal_salivary_gland | 1.20808241 |
| 71 | MP0002163_abnormal_gland_morphology | 1.20765608 |
| 72 | MP0005464_abnormal_platelet_physiology | 1.19258228 |
| 73 | MP0002998_abnormal_bone_remodeling | 1.17745619 |
| 74 | MP0000604_amyloidosis | 1.17669957 |
| 75 | MP0008007_abnormal_cellular_replicative | 1.17152007 |
| 76 | MP0005397_hematopoietic_system_phenotyp | 1.15994645 |
| 77 | MP0001545_abnormal_hematopoietic_system | 1.15994645 |
| 78 | MP0003111_abnormal_nucleus_morphology | 1.13481512 |
| 79 | MP0005409_darkened_coat_color | 1.12863856 |
| 80 | MP0005379_endocrine/exocrine_gland_phen | 1.12433736 |
| 81 | MP0003866_abnormal_defecation | 1.12328380 |
| 82 | MP0003806_abnormal_nucleotide_metabolis | 1.12000879 |
| 83 | MP0003786_premature_aging | 1.11768666 |
| 84 | MP0008260_abnormal_autophagy | 1.11008760 |
| 85 | MP0005166_decreased_susceptibility_to | 1.10467793 |
| 86 | MP0003448_altered_tumor_morphology | 1.06905864 |
| 87 | MP0009765_abnormal_xenobiotic_induced | 1.05968181 |
| 88 | MP0010094_abnormal_chromosome_stability | 1.05089976 |
| 89 | MP0000490_abnormal_crypts_of | 1.01807018 |
| 90 | MP0000343_altered_response_to | 1.01578346 |
| 91 | MP0002876_abnormal_thyroid_physiology | 1.01462731 |
| 92 | MP0001188_hyperpigmentation | 0.99358470 |
| 93 | MP0003718_maternal_effect | 0.98849827 |
| 94 | MP0002933_joint_inflammation | 0.97543338 |
| 95 | MP0003828_pulmonary_edema | 0.95113563 |
| 96 | MP0002019_abnormal_tumor_incidence | 0.93374799 |
| 97 | MP0001663_abnormal_digestive_system | 0.92562231 |
| 98 | MP0005365_abnormal_bile_salt | 0.91388619 |
| 99 | MP0003045_fibrosis | 0.90245849 |
| 100 | MP0005164_abnormal_response_to | 0.90189710 |
| 101 | MP0000015_abnormal_ear_pigmentation | 0.89435768 |
| 102 | MP0004883_abnormal_blood_vessel | 0.88832124 |
| 103 | MP0000313_abnormal_cell_death | 0.87005162 |
| 104 | MP0006035_abnormal_mitochondrial_morpho | 0.86821354 |
| 105 | MP0008877_abnormal_DNA_methylation | 0.86387856 |
| 106 | MP0009763_increased_sensitivity_to | 0.86287387 |
| 107 | MP0008932_abnormal_embryonic_tissue | 0.84700620 |
| 108 | MP0001764_abnormal_homeostasis | 0.83744285 |
| 109 | MP0000249_abnormal_blood_vessel | 0.82566309 |
| 110 | MP0002693_abnormal_pancreas_physiology | 0.81969231 |
| 111 | MP0005390_skeleton_phenotype | 0.81655923 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.80649484 |
| 113 | MP0001533_abnormal_skeleton_physiology | 0.80282319 |
| 114 | MP0000678_abnormal_parathyroid_gland | 0.78322439 |
| 115 | MP0008004_abnormal_stomach_pH | 0.77637839 |
| 116 | MP0003690_abnormal_glial_cell | 0.75622954 |
| 117 | MP0003195_calcinosis | 0.75128344 |
| 118 | MP0003656_abnormal_erythrocyte_physiolo | 0.73483779 |
| 119 | MP0005085_abnormal_gallbladder_physiolo | 0.72982238 |
| 120 | MP0003941_abnormal_skin_development | 0.72867965 |
| 121 | MP0000609_abnormal_liver_physiology | 0.71534064 |
| 122 | MP0005167_abnormal_blood-brain_barrier | 0.71414330 |
| 123 | MP0005389_reproductive_system_phenotype | 0.69731419 |
| 124 | MP0003011_delayed_dark_adaptation | 0.69257297 |
| 125 | MP0002095_abnormal_skin_pigmentation | 0.69172826 |
| 126 | MP0002332_abnormal_exercise_endurance | 0.68995685 |
| 127 | MP0005319_abnormal_enzyme/_coenzyme | 0.68953501 |
| 128 | MP0003252_abnormal_bile_duct | 0.67994101 |
| 129 | MP0003795_abnormal_bone_structure | 0.67650461 |
| 130 | MP0009643_abnormal_urine_homeostasis | 0.66297301 |
| 131 | MP0001919_abnormal_reproductive_system | 0.65163787 |
| 132 | MP0005165_increased_susceptibility_to | 0.63390781 |
| 133 | MP0002136_abnormal_kidney_physiology | 0.63145124 |
| 134 | MP0008874_decreased_physiological_sensi | 0.62194825 |
| 135 | MP0001851_eye_inflammation | 0.61834827 |
| 136 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.61687453 |
| 137 | MP0002160_abnormal_reproductive_system | 0.61366837 |
| 138 | MP0008873_increased_physiological_sensi | 0.57980658 |
| 139 | MP0003303_peritoneal_inflammation | 0.57559536 |
| 140 | MP0008875_abnormal_xenobiotic_pharmacok | 0.56583210 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Progressive external ophthalmoplegia (HP:0000590) | 3.87396943 |
| 2 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.81403084 |
| 3 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.72851440 |
| 4 | Granulocytopenia (HP:0001913) | 3.67974081 |
| 5 | IgM deficiency (HP:0002850) | 3.61832715 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 3.60251704 |
| 7 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.46377510 |
| 8 | Abnormality of glycolipid metabolism (HP:0010969) | 3.37520882 |
| 9 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.37520882 |
| 10 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.37520882 |
| 11 | Spontaneous hematomas (HP:0007420) | 3.25085433 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 3.18385586 |
| 13 | Nasal polyposis (HP:0100582) | 3.15286761 |
| 14 | Increased IgM level (HP:0003496) | 3.12752691 |
| 15 | Eczematoid dermatitis (HP:0000976) | 3.10518627 |
| 16 | Eosinophilia (HP:0001880) | 3.09209232 |
| 17 | Type I transferrin isoform profile (HP:0003642) | 3.05018552 |
| 18 | Pustule (HP:0200039) | 3.04478246 |
| 19 | Recurrent bronchitis (HP:0002837) | 3.03012750 |
| 20 | IgG deficiency (HP:0004315) | 3.01335079 |
| 21 | Chronic otitis media (HP:0000389) | 2.97821898 |
| 22 | Abnormality of T cell physiology (HP:0011840) | 2.97591660 |
| 23 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.95562364 |
| 24 | Pulmonary infiltrates (HP:0002113) | 2.94627852 |
| 25 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.93911926 |
| 26 | Recurrent viral infections (HP:0004429) | 2.92193865 |
| 27 | Recurrent abscess formation (HP:0002722) | 2.89587271 |
| 28 | Abnormality of macrophages (HP:0004311) | 2.88669850 |
| 29 | Autoimmune hemolytic anemia (HP:0001890) | 2.87907747 |
| 30 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.86372056 |
| 31 | Abnormality of T cells (HP:0002843) | 2.84895880 |
| 32 | Recurrent fungal infections (HP:0002841) | 2.81596739 |
| 33 | Myositis (HP:0100614) | 2.79358990 |
| 34 | Chromsome breakage (HP:0040012) | 2.78122000 |
| 35 | Keratoconjunctivitis sicca (HP:0001097) | 2.77116451 |
| 36 | Hemoptysis (HP:0002105) | 2.76988866 |
| 37 | Urticaria (HP:0001025) | 2.75990192 |
| 38 | Abnormality of T cell number (HP:0011839) | 2.75080924 |
| 39 | Progressive muscle weakness (HP:0003323) | 2.75079028 |
| 40 | Recurrent cutaneous fungal infections (HP:0011370) | 2.74673695 |
| 41 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.74673695 |
| 42 | Colitis (HP:0002583) | 2.72679244 |
| 43 | Inflammation of the large intestine (HP:0002037) | 2.72372852 |
| 44 | Combined immunodeficiency (HP:0005387) | 2.71846822 |
| 45 | Abnormality of eosinophils (HP:0001879) | 2.71468418 |
| 46 | Chronic diarrhea (HP:0002028) | 2.71056936 |
| 47 | Increased cerebral lipofuscin (HP:0011813) | 2.70198179 |
| 48 | T lymphocytopenia (HP:0005403) | 2.69194075 |
| 49 | Reduced antithrombin III activity (HP:0001976) | 2.68554311 |
| 50 | Abnormality of B cell number (HP:0010975) | 2.67392910 |
| 51 | B lymphocytopenia (HP:0010976) | 2.67392910 |
| 52 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.67061871 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.66710752 |
| 54 | Gastrointestinal inflammation (HP:0004386) | 2.64768182 |
| 55 | Prolonged bleeding time (HP:0003010) | 2.64734380 |
| 56 | Severe combined immunodeficiency (HP:0004430) | 2.63841696 |
| 57 | Dysostosis multiplex (HP:0000943) | 2.62556794 |
| 58 | Epistaxis (HP:0000421) | 2.61263046 |
| 59 | Reticulocytopenia (HP:0001896) | 2.59749772 |
| 60 | Purpura (HP:0000979) | 2.59296879 |
| 61 | Panhypogammaglobulinemia (HP:0003139) | 2.58923593 |
| 62 | Abnormality of the nasal mucosa (HP:0000433) | 2.58918925 |
| 63 | Gingival bleeding (HP:0000225) | 2.57293797 |
| 64 | Chest pain (HP:0100749) | 2.56108219 |
| 65 | Recurrent bacterial skin infections (HP:0005406) | 2.55617649 |
| 66 | Keratoconjunctivitis (HP:0001096) | 2.52231082 |
| 67 | Breast hypoplasia (HP:0003187) | 2.51649830 |
| 68 | Pulmonary embolism (HP:0002204) | 2.50744814 |
| 69 | 3-Methylglutaconic aciduria (HP:0003535) | 2.50231472 |
| 70 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.47578251 |
| 71 | Cellulitis (HP:0100658) | 2.45463253 |
| 72 | Gastrointestinal stroma tumor (HP:0100723) | 2.42183987 |
| 73 | Arterial thrombosis (HP:0004420) | 2.40668484 |
| 74 | Encephalitis (HP:0002383) | 2.39676259 |
| 75 | Anorexia (HP:0002039) | 2.39436392 |
| 76 | Abnormality of the prostate (HP:0008775) | 2.39174856 |
| 77 | Recurrent skin infections (HP:0001581) | 2.38328623 |
| 78 | Increased serum ferritin (HP:0003281) | 2.37626391 |
| 79 | Meningitis (HP:0001287) | 2.37600171 |
| 80 | Cheilitis (HP:0100825) | 2.36636905 |
| 81 | Joint swelling (HP:0001386) | 2.33591935 |
| 82 | Obstructive lung disease (HP:0006536) | 2.32127745 |
| 83 | Chronic obstructive pulmonary disease (HP:0006510) | 2.32127745 |
| 84 | Vasculitis (HP:0002633) | 2.31633011 |
| 85 | Hypergammaglobulinemia (HP:0010702) | 2.30040234 |
| 86 | Abnormality of the pleura (HP:0002103) | 2.29643503 |
| 87 | Increased IgE level (HP:0003212) | 2.28887804 |
| 88 | Leukocytosis (HP:0001974) | 2.27545277 |
| 89 | Exertional dyspnea (HP:0002875) | 2.26112202 |
| 90 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.25357781 |
| 91 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.25357781 |
| 92 | Hepatosplenomegaly (HP:0001433) | 2.23922662 |
| 93 | Recurrent sinusitis (HP:0011108) | 2.22751555 |
| 94 | Pancytopenia (HP:0001876) | 2.21995349 |
| 95 | Retrobulbar optic neuritis (HP:0100654) | 2.19155514 |
| 96 | Optic neuritis (HP:0100653) | 2.19155514 |
| 97 | Recurrent pneumonia (HP:0006532) | 2.18428787 |
| 98 | Loss of speech (HP:0002371) | 2.18206910 |
| 99 | Birth length less than 3rd percentile (HP:0003561) | 2.17668067 |
| 100 | Orchitis (HP:0100796) | 2.17233605 |
| 101 | Gangrene (HP:0100758) | 2.16802312 |
| 102 | Abnormality of iron homeostasis (HP:0011031) | 2.16764760 |
| 103 | Agammaglobulinemia (HP:0004432) | 2.16242520 |
| 104 | Renal Fanconi syndrome (HP:0001994) | 2.15026912 |
| 105 | Prostate neoplasm (HP:0100787) | 2.14865580 |
| 106 | Lymphoma (HP:0002665) | 2.14001071 |
| 107 | Clubbing of toes (HP:0100760) | 2.11931816 |
| 108 | IgA deficiency (HP:0002720) | 2.11547809 |
| 109 | Proximal tubulopathy (HP:0000114) | 2.10664467 |
| 110 | Abnormal protein glycosylation (HP:0012346) | 2.10503080 |
| 111 | Abnormal glycosylation (HP:0012345) | 2.10503080 |
| 112 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.10503080 |
| 113 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.10503080 |
| 114 | Mediastinal lymphadenopathy (HP:0100721) | 2.10008520 |
| 115 | Macrocytic anemia (HP:0001972) | 2.09997229 |
| 116 | Gingivitis (HP:0000230) | 2.09699293 |
| 117 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.07157239 |
| 118 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.07157239 |
| 119 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.07157239 |
| 120 | Bronchitis (HP:0012387) | 2.06961747 |
| 121 | Glomerulonephritis (HP:0000099) | 2.06945009 |
| 122 | Thrombocytosis (HP:0001894) | 2.05830723 |
| 123 | Stomatitis (HP:0010280) | 2.03785058 |
| 124 | Vacuolated lymphocytes (HP:0001922) | 2.03299821 |
| 125 | Restrictive lung disease (HP:0002091) | 2.02893970 |
| 126 | Acne (HP:0001061) | 2.01438571 |
| 127 | Skin rash (HP:0000988) | 2.00942587 |
| 128 | Abnormality of the preputium (HP:0100587) | 2.00863564 |
| 129 | Amyloidosis (HP:0011034) | 2.00656491 |
| 130 | Meckel diverticulum (HP:0002245) | 1.99886664 |
| 131 | Aplastic anemia (HP:0001915) | 1.99836947 |
| 132 | Aplasia/hypoplasia of the uterus (HP:0008684) | 1.99653546 |
| 133 | Petechiae (HP:0000967) | 1.99191103 |
| 134 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.98344719 |
| 135 | Sepsis (HP:0100806) | 1.98029159 |
| 136 | Osteomyelitis (HP:0002754) | 1.96558335 |
| 137 | Cleft eyelid (HP:0000625) | 1.96296209 |
| 138 | Mucopolysacchariduria (HP:0008155) | 1.96243210 |
| 139 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.95303872 |
| 140 | Lymphopenia (HP:0001888) | 1.94227449 |
| 141 | Duplicated collecting system (HP:0000081) | 1.93958633 |
| 142 | Microretrognathia (HP:0000308) | 1.93133049 |
| 143 | Chronic sinusitis (HP:0011109) | 1.92908082 |
| 144 | Pallor (HP:0000980) | 1.92538380 |
| 145 | External ophthalmoplegia (HP:0000544) | 1.92375427 |
| 146 | Recurrent lower respiratory tract infections (HP:0002783) | 1.92254251 |
| 147 | Prolonged neonatal jaundice (HP:0006579) | 1.89648593 |
| 148 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.89581230 |
| 149 | Bone marrow hypocellularity (HP:0005528) | 1.87952168 |
| 150 | Abnormality of the ileum (HP:0001549) | 1.87508424 |
| 151 | Bronchiectasis (HP:0002110) | 1.87304742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRAK3 | 5.68535724 |
| 2 | IRAK4 | 3.95443773 |
| 3 | RIPK4 | 3.78517607 |
| 4 | STK16 | 2.98589458 |
| 5 | PLK4 | 2.96749909 |
| 6 | IRAK1 | 2.70278407 |
| 7 | TXK | 2.42187637 |
| 8 | MAP2K3 | 2.38331628 |
| 9 | BLK | 2.31934067 |
| 10 | BUB1 | 2.26306199 |
| 11 | MAP4K1 | 2.23554183 |
| 12 | TYK2 | 2.19421922 |
| 13 | IRAK2 | 2.18574246 |
| 14 | MAP3K14 | 2.17550724 |
| 15 | ZAK | 2.11446201 |
| 16 | EIF2AK3 | 2.10906313 |
| 17 | IKBKE | 1.97799090 |
| 18 | MAP3K11 | 1.89036835 |
| 19 | TNK2 | 1.82172840 |
| 20 | MAP3K3 | 1.78007873 |
| 21 | NME2 | 1.72559296 |
| 22 | IKBKB | 1.68526402 |
| 23 | JAK3 | 1.62616418 |
| 24 | PRPF4B | 1.58219682 |
| 25 | GRK6 | 1.50283650 |
| 26 | MST4 | 1.49635024 |
| 27 | KIT | 1.48166311 |
| 28 | TESK2 | 1.45778276 |
| 29 | EIF2AK1 | 1.44989787 |
| 30 | ADRBK2 | 1.41687489 |
| 31 | FGFR4 | 1.40850176 |
| 32 | RIPK1 | 1.40407778 |
| 33 | TEC | 1.40209174 |
| 34 | GRK1 | 1.38576027 |
| 35 | PIM2 | 1.37202074 |
| 36 | TBK1 | 1.31001403 |
| 37 | SRPK1 | 1.30556360 |
| 38 | TLK1 | 1.29932238 |
| 39 | VRK1 | 1.29617853 |
| 40 | ACVR1B | 1.26570646 |
| 41 | BMPR1B | 1.24589318 |
| 42 | PBK | 1.20138517 |
| 43 | KDR | 1.18759401 |
| 44 | ZAP70 | 1.17626367 |
| 45 | NLK | 1.17451946 |
| 46 | FGR | 1.16972232 |
| 47 | EIF2AK2 | 1.13024755 |
| 48 | JAK2 | 1.11057431 |
| 49 | STK10 | 1.01974920 |
| 50 | MAP3K1 | 0.99002570 |
| 51 | MAP2K2 | 0.98461250 |
| 52 | TAOK1 | 0.98254751 |
| 53 | TAOK3 | 0.98029463 |
| 54 | BTK | 0.97429595 |
| 55 | TRIB3 | 0.93490025 |
| 56 | WEE1 | 0.92428354 |
| 57 | ITK | 0.92013772 |
| 58 | CHUK | 0.91930161 |
| 59 | CSF1R | 0.90939163 |
| 60 | TTK | 0.88589531 |
| 61 | GRK7 | 0.87761225 |
| 62 | LCK | 0.87732440 |
| 63 | EPHA3 | 0.86665169 |
| 64 | JAK1 | 0.86001209 |
| 65 | SYK | 0.85716139 |
| 66 | TIE1 | 0.84985054 |
| 67 | CSK | 0.84265204 |
| 68 | RPS6KA5 | 0.84105328 |
| 69 | EPHB1 | 0.79567683 |
| 70 | TAOK2 | 0.78830575 |
| 71 | TSSK6 | 0.78176525 |
| 72 | EPHA2 | 0.76854295 |
| 73 | BCKDK | 0.76341958 |
| 74 | PDK1 | 0.75803828 |
| 75 | LYN | 0.75003506 |
| 76 | PTK6 | 0.70749247 |
| 77 | MAPK11 | 0.69878849 |
| 78 | MAPK7 | 0.69129740 |
| 79 | SIK3 | 0.67806138 |
| 80 | BMPR2 | 0.66175105 |
| 81 | STK4 | 0.65718755 |
| 82 | CDC42BPA | 0.65325926 |
| 83 | PIM1 | 0.63919049 |
| 84 | SMG1 | 0.63241200 |
| 85 | MAP3K7 | 0.63050792 |
| 86 | MAPK12 | 0.62945690 |
| 87 | FES | 0.62671825 |
| 88 | DYRK3 | 0.62635563 |
| 89 | PDPK1 | 0.62063731 |
| 90 | MAP3K6 | 0.62032282 |
| 91 | MAP3K13 | 0.60890636 |
| 92 | CLK1 | 0.59930134 |
| 93 | RPS6KA4 | 0.59696816 |
| 94 | FYN | 0.58409640 |
| 95 | PLK1 | 0.57940251 |
| 96 | BRSK2 | 0.57340528 |
| 97 | PRKD2 | 0.56843062 |
| 98 | GRK5 | 0.53855052 |
| 99 | PASK | 0.49946189 |
| 100 | NME1 | 0.49829824 |
| 101 | ATR | 0.49581337 |
| 102 | ABL2 | 0.48499043 |
| 103 | MAPKAPK2 | 0.47117414 |
| 104 | FGFR3 | 0.46912347 |
| 105 | ERN1 | 0.46809581 |
| 106 | LRRK2 | 0.45979062 |
| 107 | PRKCI | 0.45835091 |
| 108 | DAPK2 | 0.45293997 |
| 109 | SIK2 | 0.44274882 |
| 110 | HIPK2 | 0.42359632 |
| 111 | PIK3CA | 0.42254067 |
| 112 | MARK2 | 0.41882087 |
| 113 | MARK1 | 0.41819958 |
| 114 | HCK | 0.41146342 |
| 115 | MAP2K6 | 0.40407600 |
| 116 | CDK7 | 0.40301450 |
| 117 | MAPKAPK3 | 0.39378218 |
| 118 | MUSK | 0.38555553 |
| 119 | MAP3K5 | 0.37062985 |
| 120 | CDK12 | 0.36971083 |
| 121 | MATK | 0.35868564 |
| 122 | SIK1 | 0.35145783 |
| 123 | PRKCD | 0.34520671 |
| 124 | AURKB | 0.33908714 |
| 125 | FLT3 | 0.33533407 |
| 126 | CSNK2A1 | 0.33308563 |
| 127 | RPS6KL1 | 0.32812616 |
| 128 | RPS6KC1 | 0.32812616 |
| 129 | MAPK4 | 0.31301768 |
| 130 | ABL1 | 0.30772529 |
| 131 | MAPK3 | 0.29561115 |
| 132 | RET | 0.29532249 |
| 133 | NEK6 | 0.29350851 |
| 134 | RPS6KB2 | 0.29283644 |
| 135 | PIK3CG | 0.28689736 |
| 136 | PKN1 | 0.28013400 |
| 137 | PRKG2 | 0.27720649 |
| 138 | RPS6KA6 | 0.27629781 |
| 139 | TGFBR2 | 0.27130666 |
| 140 | PRKCQ | 0.26224702 |
| 141 | MARK3 | 0.25143293 |
| 142 | PAK4 | 0.24312642 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.33618332 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.27381437 |
| 3 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.95000561 |
| 4 | RNA polymerase_Homo sapiens_hsa03020 | 2.78727510 |
| 5 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.74854417 |
| 6 | DNA replication_Homo sapiens_hsa03030 | 2.68039794 |
| 7 | Protein export_Homo sapiens_hsa03060 | 2.37124491 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.34249765 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.31824478 |
| 10 | Mismatch repair_Homo sapiens_hsa03430 | 2.16263729 |
| 11 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.12577363 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.05668302 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.01775222 |
| 14 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.97831847 |
| 15 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.79970132 |
| 16 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.76212352 |
| 17 | Viral myocarditis_Homo sapiens_hsa05416 | 1.69455318 |
| 18 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.69075171 |
| 19 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.63969193 |
| 20 | Spliceosome_Homo sapiens_hsa03040 | 1.61967275 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.61503979 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.61114562 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.57593806 |
| 24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.47405334 |
| 25 | Base excision repair_Homo sapiens_hsa03410 | 1.45489136 |
| 26 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.38794733 |
| 27 | Basal transcription factors_Homo sapiens_hsa03022 | 1.36652733 |
| 28 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.35848747 |
| 29 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.35188072 |
| 30 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.34652512 |
| 31 | Leishmaniasis_Homo sapiens_hsa05140 | 1.34136563 |
| 32 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.32701997 |
| 33 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.31998140 |
| 34 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.28718546 |
| 35 | Asthma_Homo sapiens_hsa05310 | 1.28169453 |
| 36 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.27378962 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.25135604 |
| 38 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23698612 |
| 39 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.21452589 |
| 40 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.20527177 |
| 41 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.13451165 |
| 42 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.05883580 |
| 43 | Parkinsons disease_Homo sapiens_hsa05012 | 1.05692818 |
| 44 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.04849114 |
| 45 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.04782466 |
| 46 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.03074205 |
| 47 | Phagosome_Homo sapiens_hsa04145 | 1.02972869 |
| 48 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.02855499 |
| 49 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.02245828 |
| 50 | Purine metabolism_Homo sapiens_hsa00230 | 1.00904986 |
| 51 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.99229309 |
| 52 | RNA degradation_Homo sapiens_hsa03018 | 0.99147724 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.98876276 |
| 54 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.98597860 |
| 55 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.98579335 |
| 56 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.97946643 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.97315562 |
| 58 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.95313930 |
| 59 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.94389497 |
| 60 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.94217362 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.93959141 |
| 62 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90174551 |
| 63 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.89526216 |
| 64 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.89211985 |
| 65 | RNA transport_Homo sapiens_hsa03013 | 0.87662487 |
| 66 | Salmonella infection_Homo sapiens_hsa05132 | 0.87623345 |
| 67 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.87550375 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.84458932 |
| 69 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.84158956 |
| 70 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.83781438 |
| 71 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.82744393 |
| 72 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.81806339 |
| 73 | Huntingtons disease_Homo sapiens_hsa05016 | 0.79888426 |
| 74 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.79245194 |
| 75 | Pertussis_Homo sapiens_hsa05133 | 0.79168545 |
| 76 | Histidine metabolism_Homo sapiens_hsa00340 | 0.78548369 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.78329048 |
| 78 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.78269643 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.73986619 |
| 80 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.71939510 |
| 81 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.70559503 |
| 82 | Legionellosis_Homo sapiens_hsa05134 | 0.70422493 |
| 83 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.68489939 |
| 84 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.68320464 |
| 85 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.67823042 |
| 86 | Hepatitis B_Homo sapiens_hsa05161 | 0.65848620 |
| 87 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.62384655 |
| 88 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.61199164 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.61003569 |
| 90 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.60209065 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.59319753 |
| 92 | Alzheimers disease_Homo sapiens_hsa05010 | 0.58397480 |
| 93 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.58300233 |
| 94 | Apoptosis_Homo sapiens_hsa04210 | 0.56972977 |
| 95 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.52879860 |
| 96 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.51492056 |
| 97 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.51028952 |
| 98 | Hepatitis C_Homo sapiens_hsa05160 | 0.50909951 |
| 99 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.50811957 |
| 100 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.50400843 |
| 101 | Cell cycle_Homo sapiens_hsa04110 | 0.50111437 |
| 102 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.49960632 |
| 103 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49593068 |
| 104 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.48263021 |
| 105 | ABC transporters_Homo sapiens_hsa02010 | 0.48216305 |
| 106 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48112818 |
| 107 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.46915881 |
| 108 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.46844879 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.46811617 |
| 110 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46367332 |
| 111 | Shigellosis_Homo sapiens_hsa05131 | 0.44612700 |
| 112 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.44579421 |
| 113 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.44549594 |
| 114 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.43310312 |
| 115 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.43295302 |
| 116 | Malaria_Homo sapiens_hsa05144 | 0.43053143 |
| 117 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.42904492 |
| 118 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.41161129 |
| 119 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40295186 |
| 120 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.39745871 |
| 121 | Tuberculosis_Homo sapiens_hsa05152 | 0.38852340 |
| 122 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.38570778 |
| 123 | HTLV-I infection_Homo sapiens_hsa05166 | 0.38443219 |
| 124 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38039001 |
| 125 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.37907208 |
| 126 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.37772269 |
| 127 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.36986823 |
| 128 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36974311 |
| 129 | Insulin resistance_Homo sapiens_hsa04931 | 0.36637453 |
| 130 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36553629 |
| 131 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.36313607 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34836458 |
| 133 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.34058508 |
| 134 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.33620200 |
| 135 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.32863696 |
| 136 | Endocytosis_Homo sapiens_hsa04144 | 0.32252596 |
| 137 | Amoebiasis_Homo sapiens_hsa05146 | 0.32221094 |
| 138 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.31113728 |
| 139 | Prion diseases_Homo sapiens_hsa05020 | 0.30914598 |
| 140 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.30869304 |
| 141 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.29657570 |
| 142 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.27608345 |
| 143 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.25163361 |
| 144 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.23049567 |
| 145 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.22992630 |
| 146 | Retinol metabolism_Homo sapiens_hsa00830 | 0.20400857 |

